GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonoscape Medical Corp (SZSE:300633) » Definitions » Cyclically Adjusted PS Ratio

Sonoscape Medical (SZSE:300633) Cyclically Adjusted PS Ratio : 9.57 (As of Jun. 04, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Sonoscape Medical Cyclically Adjusted PS Ratio?

As of today (2025-06-04), Sonoscape Medical's current share price is ¥33.68. Sonoscape Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥3.52. Sonoscape Medical's Cyclically Adjusted PS Ratio for today is 9.57.

The historical rank and industry rank for Sonoscape Medical's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:300633' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 7.76   Med: 8.8   Max: 11.38
Current: 9.26

During the past years, Sonoscape Medical's highest Cyclically Adjusted PS Ratio was 11.38. The lowest was 7.76. And the median was 8.80.

SZSE:300633's Cyclically Adjusted PS Ratio is ranked worse than
85.54% of 484 companies
in the Medical Devices & Instruments industry
Industry Median: 2.215 vs SZSE:300633: 9.26

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sonoscape Medical's adjusted revenue per share data for the three months ended in Mar. 2025 was ¥0.991. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥3.52 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sonoscape Medical Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sonoscape Medical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoscape Medical Cyclically Adjusted PS Ratio Chart

Sonoscape Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 8.38

Sonoscape Medical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 10.46 8.38 8.26

Competitive Comparison of Sonoscape Medical's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Sonoscape Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonoscape Medical's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonoscape Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sonoscape Medical's Cyclically Adjusted PS Ratio falls into.


;
;

Sonoscape Medical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sonoscape Medical's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=33.68/3.52
=9.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonoscape Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Sonoscape Medical's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.991/115.1156*115.1156
=0.991

Current CPI (Mar. 2025) = 115.1156.

Sonoscape Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.000 99.000 0.000
201503 0.291 99.900 0.335
201512 0.000 100.600 0.000
201603 0.264 102.200 0.297
201606 0.453 101.400 0.514
201609 0.378 102.400 0.425
201612 0.880 102.600 0.987
201703 0.445 103.200 0.496
201706 0.682 103.100 0.761
201709 0.536 104.100 0.593
201712 0.867 104.500 0.955
201803 0.577 105.300 0.631
201806 0.774 104.900 0.849
201809 0.630 106.600 0.680
201812 1.075 106.500 1.162
201903 0.576 107.700 0.616
201906 0.785 107.700 0.839
201909 0.611 109.800 0.641
201912 1.098 111.200 1.137
202003 0.576 112.300 0.590
202006 0.640 110.400 0.667
202009 0.560 111.700 0.577
202012 1.315 111.500 1.358
202103 0.704 112.662 0.719
202106 0.903 111.769 0.930
202109 0.744 112.215 0.763
202112 1.277 113.108 1.300
202203 0.866 114.335 0.872
202206 1.086 114.558 1.091
202209 0.972 115.339 0.970
202212 1.171 115.116 1.171
202303 1.100 115.116 1.100
202306 1.326 114.558 1.332
202309 0.978 115.339 0.976
202312 1.492 114.781 1.496
202403 1.109 115.227 1.108
202406 1.229 114.781 1.233
202409 0.884 115.785 0.879
202412 1.437 114.893 1.440
202503 0.991 115.116 0.991

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sonoscape Medical  (SZSE:300633) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sonoscape Medical Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sonoscape Medical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonoscape Medical Business Description

Traded in Other Exchanges
N/A
Address
Yuquan Road, 10th Floor,Yizhe Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518051
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.
Executives
Zhou Wen Ping Directors, executives
Huang Yi Bo Directors, executives
Li Hao Directors, executives
Chen Zhi Qiang Director
Wu Kun Xiang Directors, executives
Liu Ying Fang Director

Sonoscape Medical Headlines

No Headlines